Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia;Zależności pomiȩdzy wczesna̧ subiektywna̧ odpowiedzia̧ pozytywna̧ i negatywna̧ na leki przeciwpsychotyczne a czynnikami demograficznymi i nasileniem objawów psychopatologicznych wśród chorych na schizofreniȩ

Psychiatria Polska

Volumn 39, Issue 6, 2005, Pages 1185-1198

  Murawiec, Sławomir ^a,b  

^a III Klinika Psychiatryczna   (Poland)

^b Instytut Psychiatrii i Neurologii III Klinika Psychiatryczna Warszawa   (Poland)

Author keywords

Pharmacotherapy; Schizophrenia; Subjective response

Indexed keywords

CLOZAPINE; FIRST GENERATION NEUROLEPTIC AGENT; NEUROLEPTIC AGENT; RISPERIDONE; SECOND GENERATION NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG RESPONSE; EDUCATION; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SOCIAL SUPPORT; TREATMENT OUTCOME; WORK; AFFECT; DRUG EFFECT; PATIENT COMPLIANCE; QUESTIONNAIRE; SEX RATIO; STATISTICS; TIME;

ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; DEMOGRAPHY; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SCHIZOPHRENIA; SEX DISTRIBUTION; TIME FACTORS;

EID: 31044439397     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hogan TP, Awad AG. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol. Med. 1992; 22: 347-352.
2. Awad AG, Hogan TP. Subjective response to neuroleptics and the quality of life: implications for treatment outcome. Acta Psychiatr. Scand. 1994; 89 (supl. 380): 27-32.
3. Awad AG, Voruganti LNP, Heslegrave RJ, Hogan TP. Assesment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome. Int. Clin. Psychopharmacol. 1996; 11 (supl. 2): 55-59.
4. Cabeza IG, Amador MS, Lopez CA, Chavez MG, de. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors. Schizophr. Res. 2002; 41: 349-355.
5. Haley C, Drake RJ, Bentall R, Lewis SW. Class of drug treatment does not affect drug attitudes in early schizophrnia. Schizophr. Res. 2002; 53: 196 (supl.).
6. Jarema M, Murawiec S, Szafrański T, Szaniawska A, Konieczyńska Z. Subiektywna i obiektywna ocena leczenia schizofrenii lekami klasycznymi i atypowymi. Psychiatr. Pol. 2001; 35: 5-19.
7. Szafrański T, Murawiec S. Badania subiektywnych odczuć pacjentów leczonych neuroleptykami. Post. Psychiatr. Neurol. 1996; 5: 265-283.
8. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983; 13: 177-183.
9. Van Putten T, May PRA. Subjective response as a predictor of outcome in pharmacotherapy. Arch. Gen. Psychiatry 1978; 35: 477-480.
10. Van Putten T, May PRA, Marder SR, Whittman LA. Subjective response to antipsychotic drugs. Arch. Gen. Psychiatry 1981; 38: 187-190.
11. Murawiec S. "Kwestionariusz postawy wobec leku" - przedstawienie skali klinicznej. Post. Psychiatr. Neurol. 1997; 6: 325-332.